Stocktobuy
Prakash pipe looks goodPPL Has given very strong breakout.
Now waiting for a retest entry.
Keep on watchlist.
ABB Getting ready for next legABB After previous trade again getting ready for next leg if it breakouts.
Keep on watchlist.
GIPCL Pilot positionMade pilot position for GIPCL at 107.5
SL is wide (99), hence less cap and safe can avoid it and wait for a retest.
Allocated 20% trading qty.
Pin Points predictions of Bharat Forge For 1 to 5 Aug 2023Hello Traders,
This chart shows the real path that price has to follow , you just need to check below the complete way of using in your trading . Hope that explanation would help you more .
REFEX AddedTook position in REFEX at 547.5
Stock in LT ASM Stage so need to be vigilant. Also, circuit will be limited to 5%.
NSE : JBMA - JBM Auto for next rally for over 100%??NSE:JBMA
JBM Auto Ltd is an automotive company engaged in the manufacturing and sale of sheet metal components, tools, dies & moulds, and buses, including spare parts and maintenance contracts. 🚗💡🔧🚌
The Auto Components Segment: 🚘
Manufactures auto systems and high-level assemblies such as chassis & suspension systems, aesthetical parts, and BIW parts & assemblies. 🛠️🔩
The OEM Segment: ⚡🚌
Focuses on manufacturing technologically superior buses customized for different operating patterns. 📈
Developed and delivered electric buses, with an order book of around 1500 buses, including 200 electric ones. ⚡🚌
Tool Room Division: 🔧💼📐
Manufactures tools and dies for turnkey projects.
Major focus on safety critical items like chassis & suspension systems and key aesthetical parts.
Customer Base: 🌐🤝
Includes major OEMs like Ashok Leyland, Daimler, Nissan, Renault, Ford, Toyota, Volvo, Tata, and more.
Manufacturing Capabilities: 🏭📍🚚
15 manufacturing facilities strategically located near major OEM hubs.
Amalgamation of Subsidiaries: 💼🤝🔄
JB MA Automotive Pvt Ltd and JBM Auto Systems Pvt Ltd amalgamated with JBM Auto Ltd.
(Note: Please consult the original source for more detailed and up-to-date information)
Disc: Invested , second trance added today ,
Rattanindia looks interestingRattanindia looks good.
Chart is very interesting.
Have taken pilot position at 41.6
One can take entry at retest or next breakout.
RISK: Low price stock.
Bharat bijlee strongWill be taking long position in bharat bijlee.
Deploying 40% of trading allocation amount.
SL 2740
Sundarmfin looks good with small targetsSundarmfin looks good.
Range bound since 8 months.
Wait for clean breakout.
Immediate resistance might be there at 2500 and 2600 levels.
Aarti Industry for Long term buyNSE:AARTIIND for Long Term Buy above 571
Technical :
Entry Candle close above 571
SL 540
T1 593
T2 630
T3 666
T4 702
Trendline Breakout
RSI Bullish Divergence
Consolidated and created strong base
Teamlease is picking up some steam.TeamLease Services Ltd. is leading provider of human resource services in India. The company offers temporary staffing solutions, permanent recruitment services, regulatory consultancy for labour law compliance and various educational programs for employees.
TeamLease Services CMP is 2314.05. Negative aspects of the company are high valuation (P.E. = 35.5), declining cash from operations, FIIs decreasing stake and high promoter pledge. Positive aspects of the company are no debt, improving annual net profits and MFs are increasing stake.
Entry is possible after closing above 2335. Targets in the stock will be 2368 and 2397. Long term target in the stock will be 2434 and 2515. Stop loss in the stock should be maintained at closing below 2180.
Glaxosmithkline looking good. GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company. Their product offering include vaccines, speciality medicines & general medicines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease and respiratory diseases.
GlaxoSmithKline Pharmaceuticals CMP is 1390.95. Negative aspects of the company are high valuation (P.E = 38.6), declining annual net profit & MFs are decreasing stake. Positive aspects of the company are improving cash from operations, no debt & zero promoter pledge.
Entry after closing above 1402. Targets in the stock will be 1435 & 1461. Long term target in the stock will be 1489. Stop loss in the stock should be maintained at closing below 1288.
Solid looking Sun PharmaSun Pharmaceuticals Industries Ltd. is the 4th largest generic pharmaceutical company in the world. The company offers specialty medication, generic medication, over-the-counter (OTC) medication, active pharmaceutical ingredients (APIs) & anti retro viral medication. The company has the presence in more than 100 countries supported by 40 manufacturing facilities in Asia, America & Africa.
Sun Pharmaceuticals Industries CMP is 969.90. Negative aspect of the company is high valuation (P.E. = 27.5). Positive aspects of the company are Sun Pharma is a no debt company with improving annual net profits, improving cash from operations annual, promoter unpledged stake, FIIs are increasing stake, MFs are increasing stake.
Entry after closing above 974. Targets in the stock will be 1001, 1027 & 1054. Long term target in the stock will be 1073 & 1134. Stop loss in the stock should be maintained at closing below 850.
